Cargando…

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene

BACKGROUND: Dihydroartemisinin-piperaquine is a new ACT that is administered as single daily dose for three days and has been demonstrated to be tolerated and highly effective for the treatment of uncomplicated Plasmodium falciparum malaria. Piperaquine was used alone to replace chloroquine as the f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pascual, Aurélie, Madamet, Marilyn, Bertaux, Lionel, Amalvict, Rémy, Benoit, Nicolas, Travers, Dominique, Cren, Julien, Taudon, Nicolas, Rogier, Christophe, Parzy, Daniel, Pradines, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225597/ https://www.ncbi.nlm.nih.gov/pubmed/24274185 http://dx.doi.org/10.1186/1475-2875-12-431

Ejemplares similares

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
por: Dormoi, Jérome, et al.
Publicado: (2014)

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
por: Foguim, Francis Tsombeng, et al.
Publicado: (2020)

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
por: Navarro, Maribel, et al.
Publicado: (2014)

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs
por: Pascual, Aurélie, et al.
Publicado: (2011)

Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay
por: Briolant, Sébastien, et al.
Publicado: (2007)

Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015
por: Diawara, Silman, et al.
Publicado: (2017)

Prevalence of Mutations in the pfcoronin Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against Plasmodium falciparum
por: Delandre, Océane, et al.
Publicado: (2021)

Assessment of a Commercial Real-Time PCR Assay (Vitassay qPCR Malaria 5 Test) to Detect Human Malaria Infection in Travelers Returning to France
por: Madamet, Marylin, et al.
Publicado: (2022)

Comparative Assessment of the Sensitivity of Ten Commercial Rapid Diagnostic Test Kits for the Detection of Plasmodium
por: Gendrot, Mathieu, et al.
Publicado: (2022)

The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates
por: Gendrot, Mathieu, et al.
Publicado: (2018)

1H-1,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluation
por: Kumar, Kewal, et al.
Publicado: (2014)

Quinine-Resistant Malaria in Traveler Returning from French Guiana, 2010
por: Bertaux, Lionel, et al.
Publicado: (2011)

Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient
por: Roseau, Jean Baptiste, et al.
Publicado: (2016)

Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum
por: Gendrot, Mathieu, et al.
Publicado: (2021)

Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014
por: Fall, Bécaye, et al.
Publicado: (2016)

Copper (I)-Chloroquine Complexes: Interactions with DNA and Ferriprotoporphyrin, Inhibition of β-Hematin Formation and Relation to Antimalarial Activity
por: Villarreal, Wilmer, et al.
Publicado: (2022)

Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
por: Foguim Tsombeng, Francis, et al.
Publicado: (2019)

Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013
por: Torrentino-Madamet, Marylin, et al.
Publicado: (2014)

Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs
por: Foguim, Francis Tsombeng, et al.
Publicado: (2019)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2022)

Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum
por: Pascual, Aurélie, et al.
Publicado: (2012)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenaf, et al.
Publicado: (2023)

Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
por: Wurtz, Nathalie, et al.
Publicado: (2012)

Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum
por: Pradines, Bruno, et al.
Publicado: (2010)

Genetic Structure of Plasmodium falciparum and Elimination of Malaria, Comoros Archipelago
por: Rebaudet, Stanislas, et al.
Publicado: (2010)

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010)

Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
por: Loesbanluechai, Duangkamon, et al.
Publicado: (2018)

Global response of Plasmodium falciparum to hyperoxia: a combined transcriptomic and proteomic approach
por: Torrentino-Madamet, Marylin, et al.
Publicado: (2011)

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
por: Massamba, Laurencie, et al.
Publicado: (2020)

Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014)

In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na(+)/H(+ )exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo
por: Briolant, Sébastien, et al.
Publicado: (2011)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
por: Phuc, Bui Quang, et al.
Publicado: (2017)

On the Mechanism of Chloroquine Resistance in Plasmodium falciparum
por: Chinappi, Mauro, et al.
Publicado: (2010)

Chloroquine-resistant Plasmodium falciparum in Pakistan
por: Khattak, Aamer Ali, et al.
Publicado: (2021)

Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014
por: Voumbo-Matoumona, Dominique Fatima, et al.
Publicado: (2018)

A Randomized Comparison of Chloroquine versus Dihydroartemisinin–Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam
por: Thuan, Phung Duc, et al.
Publicado: (2016)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
por: Popovici, Jean, et al.
Publicado: (2018)

Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
por: Adam, Ishag, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vvumevr478n7rl0kpniulij5l2